News
-
-
-
-
-
PRESS RELEASE
FINALIZATION OF THE ACQUISITION OF LAMOUROUX, A SPECIALIST IN WINE INDUSTRY TEMPERATURE CONTROL
Oeneo Group completes acquisition of Lamouroux, enhancing Vivelys' wine industry offerings with temperature control expertise. Lamouroux fully consolidated into Oeneo Group's financial statements as of Sept 1, 2026 -
-
PRESS RELEASE
THX Pharma, BBDF and Biocodex Announce Regulatory Submissions for the Phase 3 Clinical Trial of Batten-1 in Juvenile Batten Disease (CLN3)
THX Pharma, BBDF, and Biocodex submit regulatory applications for Phase 3 trial of Batten-1, a treatment for juvenile Batten disease. Trial aims to evaluate efficacy in pediatric patients -
-
-